Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (197)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
37
2024
2915
2.720
Why?
High-Throughput Nucleotide Sequencing
7
2022
168
1.190
Why?
Genomics
10
2023
284
0.880
Why?
Mutation
14
2022
1292
0.870
Why?
Software
4
2021
274
0.870
Why?
Tumor Microenvironment
4
2024
221
0.620
Why?
Clonal Evolution
4
2020
56
0.590
Why?
Plasma Cells
6
2023
221
0.580
Why?
Computational Biology
4
2020
214
0.560
Why?
Algorithms
4
2020
613
0.510
Why?
Neoplasm Recurrence, Local
5
2024
626
0.470
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2024
111
0.450
Why?
Neoplasms
2
2020
1233
0.410
Why?
Translocation, Genetic
7
2022
263
0.410
Why?
Hematopoietic Stem Cell Transplantation
3
2024
554
0.400
Why?
Humans
45
2024
49898
0.390
Why?
Osteolysis
2
2022
75
0.390
Why?
Models, Molecular
1
2013
334
0.390
Why?
Gene Expression Profiling
9
2023
1028
0.370
Why?
Genome, Human
3
2021
110
0.360
Why?
Chromosome Aberrations
3
2023
295
0.360
Why?
Evolution, Molecular
2
2021
97
0.360
Why?
Gene Expression Regulation, Neoplastic
5
2024
824
0.360
Why?
Proteins
1
2013
347
0.340
Why?
Prognosis
11
2024
1956
0.340
Why?
Bone Marrow
3
2020
351
0.320
Why?
Epigenomics
2
2021
67
0.320
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
994
0.280
Why?
Disease Progression
7
2023
820
0.250
Why?
Gene Rearrangement
2
2023
73
0.240
Why?
Oncogenes
3
2021
57
0.240
Why?
Chemokine CXCL12
1
2024
30
0.230
Why?
Burkitt Lymphoma
1
2023
26
0.210
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
10
0.210
Why?
Gene Dosage
2
2020
78
0.210
Why?
Epigenesis, Genetic
3
2023
370
0.210
Why?
Proto-Oncogene Proteins c-akt
1
2023
155
0.210
Why?
Signal Transduction
3
2024
1608
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.200
Why?
Drug Resistance, Neoplasm
1
2024
314
0.200
Why?
Neoplasm Proteins
2
2021
321
0.200
Why?
Cell Communication
1
2022
69
0.190
Why?
Telomere Homeostasis
1
2021
10
0.190
Why?
Ubiquitination
1
2021
40
0.190
Why?
Polycomb Repressive Complex 2
1
2021
46
0.190
Why?
Chromosome Deletion
2
2023
138
0.190
Why?
Loss of Heterozygosity
2
2018
77
0.190
Why?
Lymphoma, B-Cell
1
2021
61
0.180
Why?
Positron-Emission Tomography
2
2022
286
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Sequence Analysis, DNA
2
2018
237
0.180
Why?
Cell Cycle
1
2021
226
0.180
Why?
B-Lymphocytes
1
2021
175
0.180
Why?
Cell Cycle Proteins
1
2021
167
0.180
Why?
Lymphoma, Follicular
1
2020
27
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Bone Resorption
1
2022
297
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Mice
7
2024
5658
0.160
Why?
Genes, myc
1
2019
40
0.160
Why?
Osteocytes
1
2022
214
0.160
Why?
Tumor Suppressor Protein p53
2
2017
213
0.160
Why?
Transplantation, Autologous
4
2024
462
0.150
Why?
Mutagenesis
1
2018
59
0.150
Why?
Diffusion Magnetic Resonance Imaging
1
2018
123
0.150
Why?
Genome
1
2018
65
0.150
Why?
Neoplasm, Residual
1
2018
156
0.150
Why?
Homologous Recombination
1
2018
40
0.150
Why?
Female
11
2024
26560
0.150
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.140
Why?
Survival Rate
4
2021
905
0.140
Why?
Transcriptome
2
2020
312
0.140
Why?
DNA Repair
1
2018
185
0.140
Why?
Flow Cytometry
1
2018
470
0.130
Why?
Cell Line, Tumor
3
2024
1388
0.130
Why?
DNA Copy Number Variations
3
2022
108
0.130
Why?
Aged
8
2021
9447
0.130
Why?
Aged, 80 and over
5
2021
3136
0.120
Why?
Remission Induction
3
2021
205
0.120
Why?
Genes, Neoplasm
1
2015
30
0.120
Why?
Pattern Recognition, Automated
1
2015
41
0.120
Why?
Male
11
2024
25437
0.120
Why?
Cluster Analysis
1
2015
233
0.120
Why?
Middle Aged
8
2021
12285
0.120
Why?
Animals
7
2024
13100
0.120
Why?
Follow-Up Studies
4
2021
2175
0.120
Why?
Databases, Protein
1
2013
28
0.110
Why?
Protein Structure, Secondary
1
2013
71
0.110
Why?
Sequence Alignment
1
2013
121
0.100
Why?
Amino Acid Sequence
1
2013
579
0.100
Why?
Chromatin
2
2023
137
0.100
Why?
T-Lymphocytes
2
2024
328
0.090
Why?
Adenocarcinoma
1
2015
401
0.090
Why?
Breast Neoplasms
1
2020
1183
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
256
0.090
Why?
Tumor Burden
2
2020
131
0.090
Why?
Alleles
2
2021
251
0.090
Why?
Adult
6
2021
13346
0.090
Why?
Clone Cells
2
2021
78
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
66
0.080
Why?
Histones
2
2021
295
0.080
Why?
Lung Neoplasms
1
2015
600
0.080
Why?
DNA, Neoplasm
2
2020
145
0.080
Why?
DNA Mutational Analysis
2
2020
176
0.080
Why?
Treatment Outcome
4
2020
5176
0.080
Why?
DNA Methylation
2
2023
544
0.070
Why?
Recurrence
2
2021
658
0.070
Why?
Genomic Instability
2
2018
91
0.070
Why?
Risk Factors
3
2021
3604
0.070
Why?
Cell Proliferation
2
2021
986
0.060
Why?
Internet
2
2018
261
0.060
Why?
Killer Cells, Natural
1
2024
107
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
124
0.060
Why?
Xenograft Model Antitumor Assays
1
2024
212
0.060
Why?
Antibodies
1
2024
151
0.050
Why?
Proteasome Inhibitors
1
2024
104
0.050
Why?
Integrin beta Chains
1
2023
13
0.050
Why?
Integrins
1
2023
30
0.050
Why?
Oxidative Phosphorylation
1
2023
40
0.050
Why?
B-Cell Maturation Antigen
1
2024
88
0.050
Why?
Cytogenetic Analysis
1
2023
80
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
19
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
92
0.050
Why?
Immunoglobulins
1
2023
79
0.050
Why?
Forkhead Transcription Factors
1
2023
110
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Syndecan-1
1
2021
72
0.050
Why?
Spliceosomes
1
2021
10
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
RNA Splicing
1
2021
37
0.050
Why?
Alternative Splicing
1
2021
57
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Spatio-Temporal Analysis
1
2020
9
0.050
Why?
Aneuploidy
1
2020
18
0.050
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
Ecosystem
1
2021
64
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Phosphoproteins
1
2021
111
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Single-Cell Analysis
1
2020
63
0.040
Why?
Mice, Transgenic
1
2021
543
0.040
Why?
Cell Differentiation
1
2022
649
0.040
Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
Why?
DNA
1
2023
543
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
Why?
Melphalan
1
2020
173
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
Neoplasm Invasiveness
1
2020
268
0.040
Why?
Osteoclasts
1
2022
424
0.040
Why?
Multivariate Analysis
1
2021
579
0.040
Why?
Osteogenesis
1
2022
353
0.040
Why?
Combined Modality Therapy
1
2021
638
0.040
Why?
Disease Models, Animal
1
2024
1411
0.040
Why?
Maintenance Chemotherapy
1
2019
49
0.040
Why?
Apoptosis
1
2024
1092
0.040
Why?
Cell Survival
1
2020
590
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
7
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
26
0.040
Why?
Genome-Wide Association Study
1
2018
163
0.040
Why?
Information Dissemination
1
2018
79
0.040
Why?
Reproducibility of Results
1
2021
1182
0.040
Why?
Fibroblast Growth Factors
1
2017
45
0.040
Why?
STAT3 Transcription Factor
1
2017
80
0.040
Why?
Mitogen-Activated Protein Kinases
1
2017
154
0.030
Why?
Prospective Studies
1
2023
2345
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1354
0.030
Why?
Proportional Hazards Models
1
2018
404
0.030
Why?
Thalidomide
1
2019
374
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Kaplan-Meier Estimate
1
2018
463
0.030
Why?
Cohort Studies
1
2020
1403
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Models, Genetic
1
2016
174
0.030
Why?
Antineoplastic Agents
1
2024
1175
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
139
0.030
Why?
Survival Analysis
1
2017
670
0.030
Why?
Stem Cell Transplantation
1
2016
179
0.030
Why?
Dogs
1
2015
185
0.030
Why?
Databases, Genetic
1
2015
87
0.030
Why?
Time Factors
1
2021
2891
0.030
Why?
Sequence Analysis, RNA
1
2015
88
0.030
Why?
Genetic Testing
1
2015
119
0.030
Why?
Longitudinal Studies
1
2016
693
0.030
Why?
Retrospective Studies
1
2024
6123
0.020
Why?
Child
1
2023
6844
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description